secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEPHROS INC (NEPH)
CIK:        0001196298
Form:       8-K
Filed at:   2025-03-06T23:59:59+00:00
Accession:  0001493152-25-009390
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nephros reports first annual net income; Q4 revenue up 19% YoY to $3.9M
-----------------------------------------------------------------------

- Net income of $74K for FY2024 vs net loss of $1.6M in 2023; first annual profit in company history.
- Q4 net revenue $3.9M (+19% YoY); full-year revenue flat at $14.2M with core programmatic up 9% offset by emergency decline.
- Gross margin improved to 62% for year (vs 59%) due to better supplier terms; SG&A down 14%.
- Added nearly 600 new customer sites (~$2M sales); launched 20" HydraGuard Ultrafilter for sterile processing market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1196298/000149315225009390/0001493152-25-009390-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1196298/000149315225009390/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-009390

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer